Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Attacks on Iran's Bushehr nuclear plant and on Iraq border crossing- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- Russia downs 16 drones heading for Moscow, mayor says
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- Artemis 2 astronauts are now headed to the moon. Why has it taken humanity so long to go back?
- Council removes proposal to rename park named after former president of Israel
- These Cities Led Global Jet-Setting In 2025, According To New Data
